INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 162 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,702 | -90.8% | 132,910 | -89.5% | 0.00% | – |
| Q2 2023 | $563,020 | -61.0% | 1,260,963 | -28.5% | 0.00% | – |
| Q1 2023 | $1,445,178 | -50.5% | 1,762,412 | -5.8% | 0.00% | -100.0% |
| Q4 2022 | $2,918,138 | -6.9% | 1,870,601 | +2.9% | 0.00% | 0.0% |
| Q3 2022 | $3,136,000 | +10.4% | 1,817,915 | +10.7% | 0.00% | 0.0% |
| Q2 2022 | $2,841,000 | -48.3% | 1,642,029 | +7.3% | 0.00% | -50.0% |
| Q1 2022 | $5,495,000 | -25.4% | 1,530,604 | +3.7% | 0.00% | 0.0% |
| Q4 2021 | $7,364,000 | -29.1% | 1,475,715 | +1.7% | 0.00% | -33.3% |
| Q3 2021 | $10,387,000 | -21.8% | 1,450,681 | +1.2% | 0.00% | -25.0% |
| Q2 2021 | $13,290,000 | +4.7% | 1,433,622 | +4.8% | 0.00% | -20.0% |
| Q1 2021 | $12,699,000 | +31.0% | 1,368,377 | +24.9% | 0.01% | +25.0% |
| Q4 2020 | $9,695,000 | -22.3% | 1,095,477 | +1.8% | 0.00% | -33.3% |
| Q3 2020 | $12,483,000 | -52.7% | 1,076,108 | +9.9% | 0.01% | -53.8% |
| Q2 2020 | $26,390,000 | +361.9% | 979,197 | +27.5% | 0.01% | +333.3% |
| Q1 2020 | $5,713,000 | +206.7% | 767,814 | +36.0% | 0.00% | +200.0% |
| Q4 2019 | $1,863,000 | +61.2% | 564,473 | +0.1% | 0.00% | 0.0% |
| Q3 2019 | $1,156,000 | -18.4% | 563,828 | +17.1% | 0.00% | 0.0% |
| Q2 2019 | $1,416,000 | -24.4% | 481,466 | -4.2% | 0.00% | 0.0% |
| Q1 2019 | $1,874,000 | -4.7% | 502,380 | +2.2% | 0.00% | -50.0% |
| Q4 2018 | $1,966,000 | -27.2% | 491,372 | +1.2% | 0.00% | 0.0% |
| Q3 2018 | $2,701,000 | +54.5% | 485,741 | +8.9% | 0.00% | +100.0% |
| Q2 2018 | $1,748,000 | -10.0% | 445,846 | +8.1% | 0.00% | -50.0% |
| Q1 2018 | $1,942,000 | +40.3% | 412,279 | +23.1% | 0.00% | +100.0% |
| Q4 2017 | $1,384,000 | -34.4% | 335,002 | +0.7% | 0.00% | -50.0% |
| Q3 2017 | $2,110,000 | -19.4% | 332,662 | -0.4% | 0.00% | 0.0% |
| Q2 2017 | $2,619,000 | +29.3% | 334,017 | +9.2% | 0.00% | 0.0% |
| Q1 2017 | $2,025,000 | +0.9% | 305,844 | +5.8% | 0.00% | 0.0% |
| Q4 2016 | $2,006,000 | -21.3% | 288,999 | +5.7% | 0.00% | -33.3% |
| Q3 2016 | $2,548,000 | +130.8% | 273,347 | +128.8% | 0.00% | +200.0% |
| Q2 2016 | $1,104,000 | +6.1% | 119,456 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $1,041,000 | +10.2% | 119,456 | -15.0% | 0.00% | 0.0% |
| Q4 2015 | $945,000 | +16.2% | 140,556 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $813,000 | -29.1% | 140,556 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $1,147,000 | +29.5% | 140,556 | +29.6% | 0.00% | +100.0% |
| Q1 2015 | $886,000 | -11.0% | 108,494 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $996,000 | -6.8% | 108,494 | 0.0% | 0.00% | -50.0% |
| Q3 2014 | $1,069,000 | +11.9% | 108,494 | +22.9% | 0.00% | 0.0% |
| Q2 2014 | $955,000 | – | 88,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |